Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Rosetta Genomics Ltd. Stories

2012-11-08 08:36:01

PHILADELPHIA and REHOVOT, Israel, Nov. 8, 2012 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced summoning of a shareholders meeting for the purpose of approving the appointment of Yitzhak Peterburg, M.D., Dr.P.H., MSc. (age 61) to its Board of Directors. Upon approval of this addition by the Company's shareholders, the Company's Board will consist of seven members. Dr. Peterburg is a well-regarded...

2012-10-02 02:30:31

PHILADELPHIA, REHOVOT, Israel, and PITTSBURGH, Oct. 2, 2012 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, and Precision Therapeutics, Inc. (PTI), a life science company known for its expertise in the science of personalizing cancer therapy by advancing genomic testing and bioinformatics, today announced the commercial launch of the miRview(®) mets(2 )assay in the U.S. oncology market. miRview(®)...

2012-08-29 06:25:32

PHILADELPHIA and REHOVOT, Israel, Aug. 29, 2012 /PRNewswire/ -- Rosetta Genomics Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced the sale of an additional 825,000 ordinary shares pursuant to the exercise by the underwriter of the over-allotment option granted to the underwriter in connection with Rosetta's recent public offering of 5.5 million ordinary shares at a price to the public of $5.00 per share. The gross...

2012-08-24 02:23:35

VANCOUVER, British Columbia, Aug. 24, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Freeport-McMoRan (NYSE:FCX), Marathon Oil (NYSE:MRO), Rosetta Genomics (NASDAQ:ROSG), Zynga (NASDAQ:ZNGA), Western Digital (NASDAQ:WDC), and Cirrus Logic (NASDAQ:CRUS). (Logo: http://photos.prnewswire.com/prnh/20120813/HK56225LOGO ) (Read full report by clicking the link below, you may need to copy and...

2012-08-20 02:31:36

PHILADELPHIA and REHOVOT, Israel, Aug. 20, 2012 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced the completion of three executive hires and an expansion of its commercial operations in preparation for expected sales growth of its microRNA diagnostic assays, specifically its flagship product miRview(®) mets(2). The Company recently announced a co-marketing agreement with Precision...

2012-08-13 02:26:27

PHILADELPHIA and REHOVOT, Israel, Aug. 13, 2012 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that Frost & Sullivan has recognized Rosetta Genomics with the 2012 North American Next Generation Diagnostics Entrepreneurial Company of the Year Award. A recent Frost & Sullivan analysis on the United States cancer biomarkers market confirmed the growing credibility of clinical microRNA...

2012-08-08 06:24:23

PHILADELPHIA and REHOVOT, Israel, Aug. 8, 2012 /PRNewswire/ -- Rosetta Genomics Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced the closing of an underwritten public offering of 5,500,000 ordinary shares at an offering price of $5.00 per share. The gross proceeds to Rosetta were $27.5 million, before deducting underwriting discounts and commissions and other offering expenses payable by Rosetta. In addition, Rosetta...

2012-07-24 02:29:14

PHILADELPHIA and REHOVOT, Israel, July 24, 2012 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic assays, announced today that it has entered into a co-marketing agreement for its miRview(®) mets(2) assay for the accurate identification of the tumor of origin in Cancers of Unknown or Uncertain Primary ("CUP") with Precision Therapeutics Inc., a life science company known for its expertise in the science of...

2012-06-27 14:22:15

NEW YORK, June 27, 2012 /PRNewswire/ -- Rosetta Genomics Ltd. (NasdaqGM: ROSG) will not participate in the following virtual conference: What: LHA Life Sciences & Medical Technologies Virtual Conference When: Thursday, June 28, 2012 Contact: Carolyn Curran at (212) 838-3777 or ccurran@lhai.com We have been advised by Rosetta Genomics Ltd. that they...

2011-11-04 07:30:00

PHILADELPHIA and REHOVOT, Israel, Nov. 4, 2011 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence. The study,...